The Effect of Teaching HIV-Infected Patients About HIV and Treatment
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if an HIV-education course can help under-represented,
HIV-infected patients. This study examines the areas of faithfulness to drug regimen, level
of HIV in the blood, and health status.
Phase:
Phase 3
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir Lamivudine Lamivudine, zidovudine drug combination Zidovudine